OCT, an Eastern European CRO, expands its presence in North America. In October 2017, OCT’s representative office in the U.S. has been strengthened by additional employees. In particular, the U.S. team was complemented by Anna Yanaeva, Business Development Director.
“We believe that intensification of dialogue with our U.S.-based sponsors is a logical continuation of our business development in the region. We are convinced that the quality of our services meets the highest international standards of modern clinical trials. It is well known that high levels of service within the industry are determined by experience, knowledge and commitment to hard work. All these factors made us the biggest and the most professional CRO team in our native market,” said OCT President Dmitry Sharov.